{"id":713,"date":"2014-04-02T15:52:50","date_gmt":"2014-04-02T12:52:50","guid":{"rendered":"https:\/\/staging.iasispharma.com\/en\/?p=713"},"modified":"2026-10-30T13:29:55","modified_gmt":"2026-10-30T11:29:55","slug":"contrahist-press-release","status":"publish","type":"post","link":"https:\/\/iasispharma.com\/en\/all-articles\/contrahist-press-release\/","title":{"rendered":"CONTRAHIST PRESS RELEASE"},"content":{"rendered":"<p><strong>IASIS PHARMA<\/strong> has launched a new pharmaceutical product under the brand name <strong>Contrahist<\/strong> (as <strong>levocetirizine dihydrochloride<\/strong>). It is a non-sedative <a href=\"http:\/\/en.wikipedia.org\/wiki\/Antihistamine\">antihistamine<\/a> and is available as <strong>5 mg-strength f.c tablets<\/strong> and a <strong>0.5 mg\/mL oral solution<\/strong>. <strong>Contrahist<\/strong> is the <strong>1st generic <\/strong><strong>levocetirizine<\/strong>, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical industry<strong>.<\/strong> The excellent<strong> <em>wild berry flavor enhances patient compliance, especially for the<\/em><\/strong> <em>paediatric patient.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IASIS PHARMA has launched a new pharmaceutical product under the brand name Contrahist (as levocetirizine dihydrochloride). It is a non-sedative antihistamine and is available as 5 mg-strength f.c tablets and a 0.5 mg\/mL oral solution. Contrahist is the 1st generic levocetirizine, which has been successfully launched in the Greek pharmaceutical market by a Greek pharmaceutical  [&#8230;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[33,146],"tags":[],"class_list":["post-713","post","type-post","status-publish","format-standard","hentry","category-all-articles","category-product-launches"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7HJeP-bv","jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/comments?post=713"}],"version-history":[{"count":1,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/713\/revisions"}],"predecessor-version":[{"id":714,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/posts\/713\/revisions\/714"}],"wp:attachment":[{"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/media?parent=713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/categories?post=713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iasispharma.com\/en\/wp-json\/wp\/v2\/tags?post=713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}